Speakers

Dr. Chaoju Xiao, R&D Formulation Director at Fresenius Kabi USA, leads the development of complex generic products. She brings over 15 years of industry experience and has made significant contributions to the list of accessible essential medicines. Her expertise spans colloidal systems, peptide combination products, and controlled-release dosage forms. Dr. Chaoju Xiao earned her Ph.D. in Pharmaceutical Sciences from the University of Tennessee Health Science Center.